Literature DB >> 12874225

Positive modulation of IL-12 signaling by sphingosine kinase 2 associating with the IL-12 receptor beta 1 cytoplasmic region.

Takayuki Yoshimoto1, Masae Furuhata, Sadahiro Kamiya, Masayuki Hisada, Hiroko Miyaji, Yasushi Magami, Koh Yamamoto, Hiromi Fujiwara, Junichiro Mizuguchi.   

Abstract

IL-12 is a key immunoregulatory cytokine that promotes Th1 differentiation and cell-mediated immune responses. IL-12 stimulation results in the activation of Janus kinase 2 and tyrosine kinase 2 and, subsequently, STAT4 and STAT3. In addition, mitogen-activated protein kinase kinase 6/p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways have been recently demonstrated to be activated by IL-12 and play an important role in IL-12 signaling. To further elucidate the molecular mechanism underlying IL-12 signaling, we have performed a yeast two-hybrid screening and identified mouse sphingosine kinase 2 (SPHK2) as a molecule associating with the mouse IL-12Rbeta1 cytoplasmic region. Analyses of various mutants of each molecule revealed that the region including the proline-rich domain in SPHK2 is probably responsible for the binding to IL-12Rbeta1, while the regions including the carboxyl terminus and Box II in the IL-12Rbeta1 cytoplasmic region appear to be involved in the binding to SPHK2. Transient expression of wild-type SPHK2 in T cell hybridoma augmented IL-12-induced STAT4-mediated transcriptional activation. Ectopic expression of dominant-negative SPHK2 in Th1 cell clone significantly reduced IL-12-induced IFN-gamma production, while that of wild-type SPHK2 enhanced it. In contrast, the expression minimally affected IL-12-induced proliferation. A similar decrease in IL-12-induced IFN-gamma production was observed when dominant-negative SPHK2 was expressed in activated primary T cells using a retroviral expression system. These results suggest that SPHK2 associates with the IL-12Rbeta1 cytoplasmic region and probably plays a role in modulating IL-12 signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874225     DOI: 10.4049/jimmunol.171.3.1352

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

Review 2.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

3.  Determination of sphingosine kinase activity for cellular signaling studies.

Authors:  Katherine J Lee; Simon M Mwongela; Sumith Kottegoda; Laura Borland; Allison R Nelson; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2008-01-16       Impact factor: 6.986

Review 4.  Extracellular and intracellular actions of sphingosine-1-phosphate.

Authors:  Graham M Strub; Michael Maceyka; Nitai C Hait; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitis.

Authors:  Mark Barbour; Melissa McNaughton; Stephanie D Boomkamp; Neil MacRitchie; Hui-Rong Jiang; Nigel J Pyne; Susan Pyne
Journal:  Br J Pharmacol       Date:  2016-12-20       Impact factor: 8.739

6.  BACE1 activity is modulated by cell-associated sphingosine-1-phosphate.

Authors:  Nobumasa Takasugi; Tomoki Sasaki; Kunimichi Suzuki; Satoko Osawa; Hayato Isshiki; Yukiko Hori; Naoaki Shimada; Takuya Higo; Satoshi Yokoshima; Tohru Fukuyama; Virginia M-Y Lee; John Q Trojanowski; Taisuke Tomita; Takeshi Iwatsubo
Journal:  J Neurosci       Date:  2011-05-04       Impact factor: 6.167

Review 7.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

Review 8.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

Authors:  Deborah A Lebman; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-04-02       Impact factor: 5.922

9.  Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

Authors:  Masanori Matsui; Osamu Moriya; Maria Laura Belladonna; Sadahiro Kamiya; François A Lemonnier; Takayuki Yoshimoto; Toshitaka Akatsuka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  EBV-induced gene 3 augments IL-23Rα protein expression through a chaperone calnexin.

Authors:  Izuru Mizoguchi; Mio Ohashi; Hideaki Hasegawa; Yukino Chiba; Naoko Orii; Shinya Inoue; Chiaki Kawana; Mingli Xu; Katsuko Sudo; Koji Fujita; Masahiko Kuroda; Shin-Ichi Hashimoto; Kouji Matsushima; Takayuki Yoshimoto
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.